Cellebrite DI Ltd (NASDAQ: CLBT), a leading provider of digital intelligence solutions, saw its stock price plummet by 10.87% in pre-market trading on Thursday, February 13, 2025, despite reporting solid fourth-quarter and full-year 2024 financial results.

For the fourth quarter of 2024, Cellebrite reported adjusted earnings of $0.10 per share, meeting analyst expectations. The company's revenue rose 17.2% year-over-year to $109 million, surpassing analyst estimates of $107.18 million. This strong performance was driven by a 21% increase in subscription revenue.

For the full year 2024, Cellebrite's revenue reached $401.2 million, up 23% from the previous year. The company achieved an adjusted EBITDA margin of 24.8%, showcasing its ability to generate robust profitability and cash flow.

Looking ahead, Cellebrite provided an optimistic outlook for the first quarter of 2025 and the full year. The company expects revenue in the range of $480 million to $490 million for 2025, representing a growth of 20% to 22% compared to 2024. Additionally, Cellebrite forecasts an adjusted EBITDA margin of 24% to 25% for the full year.

Despite the strong financial performance and positive guidance, Cellebrite's stock price experienced a significant decline, suggesting a potential overreaction from the market. Analysts and industry experts have praised the company's execution and its ability to capitalize on the growing demand for digital intelligence solutions.